降低脂质的目标的不断变化:从分子机制到转化影响
在PubMed上查看摘要
概括
此摘要是机器生成的。新的降脂标解决了超出LDL-C的残留心血管风险. 新兴疗法侧重于甘油三,阿波利波蛋白B和脂质蛋白 (a) 以改善患者的治疗结果.
科学领域
- 心血管医学
- 代谢疾病
- 药理学
背景情况
- 心血管疾病是全球主要的健康问题.
- 血脂缺血是心血管疾病的主要可改变的危险因素.
- 虽然低密度脂蛋白胆固醇 (LDL-C) 是主要的治疗点,但由于其他脂蛋白,如甘油三,非脂蛋白B (apoB) 和脂蛋白a (Lpa) 存在残留风险.
研究的目的
- 审查当前和新兴的降脂疗法及其目标.
- 强调除了LDL-C之外的向因素对于降低残留心血管风险的重要性.
- 讨论治疗失脂症的新方法.
主要方法
- 关于脂质代谢和治疗点的当前科学文献的审查.
- 对现有和新型降脂药物的作用机制的分析.
- 讨论正在进行的脂蛋白修饰和心血管风险降低的研究.
主要成果
- 达类药物,贝佩多酸,PCSK9抑制剂和埃泽蒂米布向胆固醇生物合成,吸收和LDL受体通路.
- 新兴的目标如ANGPTL3和apoC-III为降低甘油三和LDL-C提供了新的途径.
- 为了进一步降低心血管风险,正在研究CETP的抑制和针对Lp (a) 的策略.
结论
- 脂质和脂质蛋白降低目标的范围正在迅速扩大.
- 新型疗法为耐药性脂质失调或特定脂质异常的患者提供了新的选择.
- 针对更广泛的脂蛋白对于全面的心血管风险管理至关重要.
相关概念视频
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Fats and lipids are crucial components in the human body. Some lipid-derived compounds, such as fat-soluble vitamins, eicosanoids, lipoproteins, and glycolipids, also play unique roles to support various biological processes .
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Receptor tyrosine kinases:
Receptor tyrosine kinases (RTKs) phosphorylate specific tyrosines on the signaling proteins. RTKs include various growth factor receptors,...

